Indonesia vs Iran (Islamic Republic of): Percentage of bloodstream infection due to Escherichia coli resistant
Indonesia
69.7%
in 2022
Iran (Islamic Republic of)
70.6%
in 2022
Indonesia rank
8th
Iran (Islamic Republic of) rank
7th
Percentage of bloodstream infection due to Escherichia coli resistant over time
- Indonesia
- Iran (Islamic Republic of)
How they compare
Iran (Islamic Republic of) currently reports 70.6% against 69.7% in Indonesia, a difference of 0.9%.
The two have swapped places 3 times across 5 shared years of data; in 2018 it was Indonesia ahead.
Indonesia ranks 8th and Iran (Islamic Republic of) ranks 7th of 50 countries.
Indonesia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Indonesia | Iran (Islamic Republic of) | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 71.0% | 67.9% | 3.1% | Indonesia |
| 2020s | 72.2% | 70.0% | 2.1% | Indonesia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher percentage of bloodstream infection due to escherichia coli resistant, Indonesia or Iran (Islamic Republic of)?
- Iran (Islamic Republic of), at 70.6% against 69.7% in Indonesia as of 2022.
- What is the difference in percentage of bloodstream infection due to escherichia coli resistant between Indonesia and Iran (Islamic Republic of)?
- 0.9%, with Iran (Islamic Republic of) ahead.
- How many years of comparable data are there for Indonesia and Iran (Islamic Republic of)?
- 5 years are reported by both, from 2018 to 2022.
- How do Indonesia and Iran (Islamic Republic of) rank globally for percentage of bloodstream infection due to escherichia coli resistant?
- Indonesia ranks 8th and Iran (Islamic Republic of) ranks 7th of 50 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.